|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/30 | |
| C07K 16/32 | |||
| C12N 15/13 | |||
| C12N 15/63 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| G01N 33/53 |
| (11) | Patento numeris | 3115377 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15879721.7 |
| Europos patento paraiškos padavimo data | 2015-12-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-01-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2015/096674 |
| Data | 2015-12-08 |
| (87) | Numeris | WO 2016/119523 |
| Data | 2016-08-04 |
| (30) | Numeris | Data | Šalis |
| 201510051280 | 2015-01-30 | CN |
| (72) |
ZHOU, Qing, CN
SHU, Mengjun, CN
HE, Zhuzi, CN
LIN, Jun, CN
|
| (73) |
Genor Biopharma Co., Ltd,
1690 Zhangheng Road Building 3 Floor 1-4 Zhangjiang Pudong, Shanghai 201203,
CN
|
| (54) | MUTANT ANTIBODY OF FULL HUMAN HER2 ANTIBODY, CODING GENE AND USE THEREOF |
| MUTANT ANTIBODY OF FULL HUMAN HER2 ANTIBODY, CODING GENE AND USE THEREOF |